Article
Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response.
Journal of viral hepatitis - 1 Feb 2012
Craxi A, Koutsounas S, Ogurtsov P, Chemello L, Maticic M, Torras J, Diago M, Tartaglione M T, Witthoeft T, Yu X, Faruqi R, Chaudhri E, Pedicone L D, Zuckerman E
Abstract excerpt
In chronic hepatitis C (CHC), treatment duration may be individualized according to time to first undetectable hepatitis C virus (HCV) RNA, with patients who attain undetectable HCV RNA early in treatment being candidates for shorter regimens. The aim of this study was to determine the relapse rate in patients with CHC genotype (G) 1 infection and low baseline viral load who achieved undetectable HCV RNA by week...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.